Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1096 AL 1110

Diagnosing multiple system atrophy at the prodromal stage

Xia C, Postuma RB.

Clin Auton Res. 2020 Jun;30(3):197-205. doi: 10.1007/s10286-020-00682-5. Epub 2020 Mar 30.

[Olfactory Dysfunctions: References to Neuropsychiatric Disorders and Diagnostics]

Waldmann S, T Lübke K, Pentzek M, Pause BM.

Fortschr Neurol Psychiatr. 2020 Mar;88(3):184-193. doi: 10.1055/a-1003-6798. Epub 2020 Mar 31.

The Effects of Task Prioritization on Dual-Tasking Postural Control in Patients With Parkinson Disease Who Have Different Postural Impairments

Hung YT, Chen LC, Wu RM, Huang CY.

Arch Phys Med Rehabil. 2020 Jul;101(7):1212-1219. doi: 10.1016/j.apmr.2020.02.014. Epub 2020 Mar 28.

The belated US FDA approval of the adenosine A(2A) receptor antagonist istradefylline for treatment of Parkinson's disease

Chen JF, Cunha RA.

Purinergic Signal. 2020 Jun;16(2):167-174. doi: 10.1007/s11302-020-09694-2. Epub 2020 Mar 31.

Evaluation of the potential of nanoparticles containing active substances in selected chronic diseases

Sarecka-Hujar B, Banyś A, Ostróżka-Cieślik A, Balwierz R, Dolińska B.

Adv Clin Exp Med. 2020 Mar;29(3):385-397. doi: 10.17219/acem/115005.

Pharmacokinetics and pharmacodynamics of levodopa/carbidopa cotherapies for Parkinson's disease

Müller T.

Expert Opin Drug Metab Toxicol. 2020 May;16(5):403-414. doi: 10.1080/17425255.2020.1750596. Epub 2020 Apr 27.

Treatment of Parkinson's Disease by MAO-B Inhibitors, New Therapies and Future Challenges - A Mini-Review

Parambi DGT.

Comb Chem High Throughput Screen. 2020;23(9):847-861. doi: 10.2174/1386207323666200402090557.

Microglia and Other Myeloid Cells in Central Nervous System Health and Disease

Gopinath A, Collins A, Khoshbouei H, Streit WJ.

J Pharmacol Exp Ther. 2020 Oct;375(1):154-160. doi: 10.1124/jpet.120.265058. Epub 2020 Apr 1.

Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial

Dobkin RD, Mann SL, Gara MA, Interian A, Rodriguez KM, Menza M.

Neurology. 2020 Apr 21;94(16):e1764-e1773. doi: 10.1212/WNL.0000000000009292. Epub 2020 Apr 1.

A call for better depression treatment in people with Parkinson disease

Pontone GM, Mills KA.

Neurology. 2020 Apr 21;94(16):691-692. doi: 10.1212/WNL.0000000000009285. Epub 2020 Apr 1.

Left Prefrontal Connectivity Links Subthalamic Stimulation with Depressive Symptoms

Irmen F, Horn A, Mosley P, Perry A, Petry-Schmelzer JN, Dafsari HS, Barbe M, Visser-Vandewalle V, Schneider GH, Li N, Kübler D, Wenzel G, Kühn AA.

Ann Neurol. 2020 Jun;87(6):962-975. doi: 10.1002/ana.25734. Epub 2020 Apr 30.

Research criteria for the diagnosis of prodromal dementia with Lewy bodies

McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P; prodromal DLB Diagnostic Study Group.

Neurology. 2020 Apr 28;94(17):743-755. doi: 10.1212/WNL.0000000000009323. Epub 2020 Apr 2.

The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson's Disease

Titze-de-Almeida SS, Soto-Sánchez C, Fernandez E, Koprich JB, Brotchie JM, Titze-de-Almeida R.

Cells. 2020 Mar 31;9(4):841. doi: 10.3390/cells9040841.

A Novel DBS Paradigm for Axial Features in Parkinson's Disease: A Randomized Crossover Study

Karl JA, Ouyang B, Goetz S, Metman LV.

Mov Disord. 2020 Aug;35(8):1369-1378. doi: 10.1002/mds.28048. Epub 2020 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias